{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:04Z","timestamp":1787004784855,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1053\/j.ackd.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T20:32:58Z","timestamp":1575923578000},"page":"484-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Calciphylaxis: Approach to Diagnosis and Management"],"prefix":"10.1053","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-1022","authenticated-orcid":false,"given":"Harish","family":"Seethapathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-0383","authenticated-orcid":false,"given":"Lama","family":"Noureddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1053\/j.ackd.2019.09.005_bib1","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.ackd.2019.09.005_bib2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.mayocp.2016.06.025","article-title":"Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis","volume":"91","author":"McCarthy","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ndt\/gfv438","article-title":"Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry","volume":"32","author":"Brandenburg","year":"2017","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"10.1053\/j.ackd.2019.09.005_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2018.06.001","article-title":"Calciphylaxis in patients with normal renal function: a case series and systematic review","volume":"93","author":"Bajaj","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1681\/ASN.2015091065","article-title":"A nationally representative study of calcific uremic arteriolopathy risk factors","volume":"27","author":"Nigwekar","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: a systematic review","volume":"3","author":"Nigwekar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.005_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamadermatol.2017.4920","article-title":"Association between hypercoagulable conditions and calciphylaxis in patients with renal disease","volume":"154","author":"Dobry","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1053\/j.ackd.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s11255-017-1721-9","article-title":"Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy","volume":"49","author":"Santos","year":"2017","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaad.2007.12.006","article-title":"Pathogenesis of calciphylaxis: Hans Selye to nuclear factor \u03ba-B","volume":"58","author":"Weenig","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.005_bib10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1681\/ASN.2016060651","article-title":"Vitamin K-dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis","volume":"28","author":"Nigwekar","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.ajkd.2006.11.041","article-title":"Subclinical vitamin K deficiency in hemodialysis patients","volume":"49","author":"Pilkey","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.005_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2014.05.005","article-title":"Adipocyte induced arterial calcification is prevented with sodium thiosulfate","volume":"449","author":"Chen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1053\/j.ackd.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.mayocp.2016.06.026","article-title":"Calciphylaxis: a disease of pannicular thrombosis","volume":"91","author":"el-Azhary","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/qjmed\/hcy234","article-title":"Review: update on the management of calciphylaxis","volume":"112","author":"Seethapathy","year":"2019","journal-title":"QJM"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.005_bib16","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/bjd.15702","article-title":"Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review","volume":"177","author":"Riemer","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.kint.2018.03.016","article-title":"Questionable specificity of histologic findings in calcific uremic arteriolopathy","volume":"94","author":"Ellis","year":"2018","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.005_bib18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/DAD.0000000000000824","article-title":"Histopathology of calciphylaxis: cohort study with clinical correlations","volume":"39","author":"Chen","year":"2017","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2019.0381","article-title":"Localization, morphologic features, and chemical composition of calciphylaxis-related skin deposits in patients with calcific uremic arteriolopathy","volume":"155","author":"Colboc","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamadermatol.2019.0051","article-title":"New debates surrounding the histopathological findings of calciphylaxis\u2014do these give us new insights into pathogenesis of the disease?","volume":"155","author":"Dominguez","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/nep.12433","article-title":"Hyperbaric oxygen in the treatment of calciphylaxis: a case series and literature review","volume":"20","author":"An","year":"2015","journal-title":"Nephrology"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1744-9987.12666","article-title":"Rheopheresis for adjuvant treatment in resistant calciphylaxis","volume":"22","author":"Bouderlique","year":"2018","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.005_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.burns.2018.09.008","article-title":"Management of calciphylaxis in a burn center: a case series and review of the literature","volume":"45","author":"Dado","year":"2019","journal-title":"Burns"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib24","first-page":"72","article-title":"Effect of a new purified collagen matrix with polyhexamethylene biguanide on recalcitrant wounds of various etiologies: a case series","volume":"30","author":"Lintzeris","year":"2018","journal-title":"Wounds A Compend Clin Res Pract"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000493975","article-title":"The effectiveness of topical cerium nitrate-silver sulfadiazine application on overall outcome in patients with calciphylaxis","volume":"235","author":"Darres","year":"2019","journal-title":"Dermatology"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib26","first-page":"310","article-title":"Calciphylaxis treated with neurolytic lumbar sympathetic block: case report and review of the literature","volume":"3","author":"Green","year":"2000","journal-title":"Reg Anesth Pain Med"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpainsymman.2018.10.514","article-title":"Palliative care use and patterns of end-of-life care in hospitalized patients with calciphylaxis","volume":"57","author":"Olaniran","year":"2019","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.005_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ekir.2018.10.002","article-title":"Treatment of calciphylaxis in CKD: a systematic review and meta-analysis","volume":"4","author":"Udomkarnjananun","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.005_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/nep.13081","article-title":"Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients","volume":"23","author":"Peng","year":"2018","journal-title":"Nephrology"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.ajkd.2016.02.040","article-title":"Sodium thiosulfate and the anion gap in patients treated by hemodialysis","volume":"68","author":"Hundemer","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ackd.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jamadermatol.2013.4565","article-title":"Intralesional sodium thiosulfate for the treatment of calciphylaxis","volume":"149","author":"Strazzula","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3747\/pdi.2011.00088","article-title":"Chemical peritonitis after intraperitoneal sodium thiosulfate","volume":"32","author":"Gupta","year":"2012","journal-title":"Perit Dial Int"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.005_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40620-019-00631-0","article-title":"Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis","volume":"32","author":"Brandenburg","year":"2019","journal-title":"J Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.005_bib34","first-page":"231","article-title":"Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates","volume":"83","author":"Torregrosa","year":"2015","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.10221014","article-title":"The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE trial","volume":"10","author":"Floege","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.005_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.03520414","article-title":"Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis","volume":"10","author":"Ishani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/089686080802800313","article-title":"Calciphylaxis: the beginning of the end","volume":"28","author":"Fine","year":"2008","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/2013.jamadermatol.5","article-title":"Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis","volume":"149","author":"el-Azhary","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamadermatol.2016.4821","article-title":"Warfarin-associated nonuremic calciphylaxis","volume":"153","author":"Yu","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"15","key":"10.1053\/j.ackd.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in end-stage kidney disease patients with atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000491881","article-title":"The successful use of apixaban in dialysis patients with calciphylaxis who require anticoagulation: a retrospective analysis","volume":"48","author":"Garza-Mayers","year":"2018","journal-title":"Am J Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/ijd.13685","article-title":"Direct oral anticoagulant medications in calciphylaxis","volume":"56","author":"King","year":"2017","journal-title":"Int J Dermatol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:01:33Z","timestamp":1761548493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559519301697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1548559519301697"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2019.09.005","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calciphylaxis: Approach to Diagnosis and Management","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}